Bioray Biotech Co., Ltd(TW:7561)
NT$15.900.00 (0.00%)
TW:7561
Bioray Biotech Co., Ltd financials statements
NT$15.90
At close:0.00 (0.00%)
Bioray Biotech Co., Ltd (7561) Income Statement
Bioray Biotech Co., Ltd Income Statement
Last quarter (Q2 2026), Bioray Biotech Co., Ltd's total revenue was NT$98.58M, an increase of 14.90% from the same quarter last year. In Q2, Bioray Biotech Co., Ltd's net income was NT$6.16M. See Bioray Biotech Co., Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 222.72M | NT$ 201.71M | NT$ 191.83M | NT$ 190.60M | NT$ 148.02M | |
| NT$ 90.57M | NT$ 79.03M | NT$ 77.65M | NT$ 80.51M | NT$ 67.29M | |
| NT$ 52.67M | NT$ 82.91M | NT$ 96.98M | NT$ 80.75M | NT$ 75.40M | |
| Depreciation and Amortization | NT$ 23.59M | NT$ 24.98M | NT$ 25.00M | NT$ 22.23M | NT$ 19.08M |
| NT$ 61.49M | NT$ 27.69M | NT$ 12.13M | NT$ 24.27M | NT$ 13.86M | |
| NT$ 37.90M | NT$ -4.32M | NT$ -19.33M | NT$ -235.00K | NT$ -8.11M | |
| NT$ 3.34M | NT$ 5.70M | NT$ 5.14M | NT$ 995.00K | NT$ 1.94M | |
| NT$ 41.24M | NT$ 1.38M | NT$ -14.19M | NT$ 682.00K | NT$ -6.17M | |
| NT$ 32.25M | NT$ 1.00M | NT$ -11.56M | NT$ 500.00K | NT$ -7.19M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.09 | NT$ 0.03 | NT$ -0.38 | NT$ 0.02 | NT$ -0.27 |
| Diluted EPS | NT$ 1.09 | NT$ 0.03 | NT$ -0.38 | NT$ 0.02 | NT$ -0.27 |
| Weighted Average Shares Outstanding | 29.59M | 29.83M | 30.09M | 28.02M | 26.77M |
| Weighted Average Shares Outstanding (Diluted) | 29.59M | 29.83M | 30.09M | 28.02M | 26.77M |
Currency in TWD
